What the analyst said

Susquehanna analyst Mehdi Hosseini raised the price target on Lam Research (NASDAQ: LRCX) to $475.00 (from $385.00) while maintaining a Positive rating.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

LRCX trades at $200. The 9 analysts who set a target in the last 3 months range from $290 to $400, with a median of $350. This $475 target is 36% above the median, the highest on the Street.

Since the note LRCX has moved −51% (from $411). 12-month window: day 130 of 365, closes on June 30, 2027.

Track record

This callOpen: LRCX has not reached $475 yet. This 12-month target is scored on June 30, 2027.

Firm track recordSusquehanna: 79% of its 14 targets at least a year old were reached within 12 months. Accuracy ranking →

Susquehanna on Lam Research

Susquehanna price targets on Lam Research

3 calls from January 29, 2026 to June 30, 2026. The target went from $325 to $475 (+46%). The rating stayed Buy.

Susquehanna targetLRCX share price
  1. June 30, 2026 This noteTarget raised from $350 (+36%)Buy$475
  2. April 9, 2026Target raised from $325 (+8%)Buy$350
  3. January 29, 2026Earliest call shownBuy$325
Share

Other analysts on Lam Research

Lynx Equity Kept rating and price target Oct 28 $400maintained BernsteinBuy Cut price target −9%, kept rating Oct 22 $350from $385 UBSBuy Cut price target −6%, kept rating Oct 22 $400from $425 Morgan StanleyBuy Cut price target −12%, kept rating Oct 22 $339from $385 Bank of AmericaBuy Cut price target −10%, kept rating Oct 22 $345from $385
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.